Phase III study of AJG511 in patients with active ulcerative colitis
Phase 3
- Conditions
- ulcerative colitis
- Registration Number
- JPRN-jRCT2080222653
- Lead Sponsor
- EA Pharma Co.,Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
Patients with active ulcerative colitis
Exclusion Criteria
Patients with a history of allergic reaction to budesonide
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method